XORTX Therapeutics Inc. (XRTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
XRTX currently has 2.24M outstanding shares. with significant dilution risk as 55.8M authorized shares could dilute existing holders by 2490.1%. The company has significantly diluted shareholders by 101.63% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 23, 2026 |
POS AM filing: This POS AM filing includes information about the offering of common shares and pre-funded warrants by the company. |
2.2M | 56M |
| Mar 20, 2026 |
20-F filing | 7.0M shares outstanding |
7M | 61M |
| Sep 25, 2025 |
F-1 filing: This F-1 filing from XORTX Therapeutics Inc. includes information about a proposed offering of common shares, pre-funded warrants, and common warrants. |
5.2M | 61M |
| May 12, 2025 |
20-F filing | 3.8M shares outstanding |
3.8M | 56M |
| Nov 15, 2024 |
F-1 filing: This F-1 filing relates to the registration of common shares underlying warrants, with the selling shareholder receiving all proceeds from the sale of common shares and the company receiving proceeds from the exercise of warrants. |
2.9M | 56M |
| May 10, 2024 |
20-F filing | 2.0M shares outstanding |
2M | 55M |
| Aug 04, 2023 |
POS AM filing: This POS AM filing is for 3,341,900 common shares issuable upon exercise of common share purchase warrants. |
15M | 55M |
| Aug 04, 2023 |
POS AM filing: This POS AM filing describes the closing of an underwritten public offering on October 7, 2022, which included common share units and pre-funded warrant units, along with the granting of an option to purchase additional common shares and/or warrants. |
15M | 55M |
| Apr 28, 2023 |
20-F filing | 15.0M shares outstanding |
15M | 55M |
| Jan 27, 2023 |
F-3 filing: XORTX Therapeutics Inc. may offer and issue common shares, warrants and units up to an aggregate initial offering price of US$50,000,000. |
13M | 55M |
| Sep 30, 2022 |
POS AM filing: This is a POS AM filing for a potential offering of common stock. The filing includes information about expenses related to the offering and legal matters. |
13M | 0 |
| Sep 08, 2022 |
F-1 filing: This is an F-1 filing detailing expenses related to a proposed offering, legal matters, experts, and SEC's position on indemnification. |
13M | 0 |
| May 03, 2022 |
20-F filing | 13.0M shares outstanding |
13M | 0 |
| Aug 12, 2021 |
F-1 filing: The F-1 filing contains information about the offer and sale of common shares, including costs and expenses related to the offering. |
N/A | 0 |